Adolescent Obesity and Insulin Resistance: Roles of Ectopic Fat Accumulation and Adipose Inflammation

Gastroenterology

Volumn 152, Issue 7, 2017, Pages 1638-1646

  Caprio, Sonia ^a   Perry, Rachel ^a   Kursawe, Romy ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JACKSON LABORATORY   (United States)

Author keywords

Adipose Tissue Distribution; Adipose Tissue Inflammation; Childhood and Adolescent Obesity; Fatty Liver; Inflammasome; Resistance

Indexed keywords

ADIPOSE TISSUE; ADOLESCENT; ADOLESCENT OBESITY; ARTICLE; BODY MASS; CARDIOMETABOLIC RISK; DISEASE SEVERITY; DYSLIPIDEMIA; ENDOPHENOTYPE; ETHNIC DIFFERENCE; FATTY LIVER; HUMAN; INFLAMMATION; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTRAPERITONEAL FAT; LIPID STORAGE; PREVALENCE; PRIORITY JOURNAL; RACE DIFFERENCE; ABDOMINAL SUBCUTANEOUS FAT; INTRAABDOMINAL FAT; LIVER; PATHOPHYSIOLOGY; PEDIATRIC OBESITY; PHYSIOLOGY;

INFLAMMASOME;

ADOLESCENT; BODY MASS INDEX; ENDOPHENOTYPES; HUMANS; INFLAMMASOMES; INFLAMMATION; INSULIN RESISTANCE; INTRA-ABDOMINAL FAT; LIVER; PEDIATRIC OBESITY; PREVALENCE; SUBCUTANEOUS FAT, ABDOMINAL;

EID: 85018661503     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2016.12.051     Document Type: Article

References (64)

1. 1 Skinner, A., Skelton, J.A., Prevalence and trends in obesity and severe obesity among children in the United States, 1999-2012. JAMA Pediatr 168 (2014), 561–566.
2. 2 Ogden, C.L., Carroll, M.D., Lawman, H.G., et al. Trends in obesity prevalence among children and adolescents in the United States, 1988–1994 through 2013–2014. JAMA 315 (2016), 2292–2299.
3. 3 Ogden, C.L., Flegal, K.M., Carroll, M.D., et al. Prevalence and trends in overweight among U.S. children and adolescents, 1999-2000. JAMA 288 (2002), 1728–1732.
4. 4 Biro, F.M., McMahon, R.P., Striegel-Moore, R., et al. Impact of timing of pubertal maturation on growth in black and white female adolescents: The National Heart, Lung, and Blood Institute Growth and Health Study. J Pediatr 138 (2001), 636–643.
5. 5 Bacha, F., Saad, R., Gungor, N., et al. Obesity, regional fat distribution, and syndrome X in obese black versus white adolescents: race differential in diabetogenic and atherogenic risk factors. J Clin Endocrinol Metab 88 (2003), 2534–2540.
6. 6 Barlow, S.E., Expert Committee. Expert committee recommendations regarding the prevention, assessment, and treatment of child and adolescent overweight and obesity: summary report. Pediatrics 120:suppl 4 (2007), S164–S192.
7. 7 Freedman, D.S., Mei, Z., Srinivasan, S.R., et al. Cardiovascular risk factors and excess adiposity among overweight children and adolescents: the Bogalusa Heart Study. J Pediatr 150 (2007), 12–17.e2.
8. 8 Whitlock, E.P., Williams, S.B., Gold, R., et al. Screening and interventions for childhood overweight: a summary of evidence for the US Preventive Services Task Force. Pediatrics 116 (2005), e125–e144.
9. 9 Skinner, A.C., Perrin, E.M., Moss, L.A., et al. Cardiometabolic risks and severity of obesity in children and young adults. N Engl J Med 373 (2015), 1307–1317.
10. 10 Weiss, R., Dziura, J., Burgert, T.S., et al. Obesity and the metabolic syndrome in children and adolescents. N Engl J Med 350 (2004), 2362–2374.
11. 11 Caprio, S., Daniels, S.R., Drewnowski, A., et al. Influence of race, ethnicity, and culture on childhood obesity: implications for prevention and treatment: a consensus statement of Shaping America's Health and the Obesity Society. Diabetes Care 31 (2008), 2211–2221.
12. 12 Sinha, R., Fisch, G., Teague, B., et al. Prevalence of impaired glucose tolerance among children and adolescents with marked obesity. N Engl J Med 346 (2002), 802–810.
13. 13 Steinberger, J., Moran, A., Hong, C.P., et al. Adiposity in childhood predicts obesity and insulin resistance in young adulthood. J Pediatr 138 (2001), 469–473.
14. 14 Srinivasan, S.R., Bao, W., Wattigney, W.A., et al. Adolescent overweight is associated with adult overweight and related multiple cardiovascular risk factors: the Bogalusa Heart Study. Metabolism 45 (1996), 235–240.
15. 15 Freedman, D.S., Khan, L.K., Dietz, W.H., et al. Relationship of childhood obesity to coronary heart disease risk factors in adulthood: the Bogalusa Heart Study. Pediatrics 108 (2001), 712–718.
16. 16 Litwin, S.E., Childhood obesity and adult cardiovascular disease. J AM Coll Cardio 64 (2014), 1588–1590.
17. 17 Odeleye, O.E., de Courten, M., Pettit, D., et al. Fasting hyperinsulinemia is a predictor of increased body weight gain and obesity in Pima Indian children. Diabetes 46 (1997), 1341–1345.
18. 18 Shulman, G., Ectopic fat in insulin resistance, dyslipidemia, and cardiometabolic disease. N Engl J Med 371 (2014), 2237–2238.
19. 19 Weiss, R., Dufour, S., Taksali, S.E., et al. Pre-type 2 diabetes in obese youth: a syndrome of impaired glucose tolerance, severe insulin resistance and altered myocellular and abdominal fat partitioning. Lancet 362 (2003), 951–957.
20. 20 Despres, J.P., Is visceral obesity the cause of the metabolic syndrome?. Ann Med 38 (2006), 52–63.
21. 21 Shulman, G.I., Cellular mechanisms of insulin resistance. J Clin Invest 106 (2000), 171–176.
22. 22 Perry, R.J., Samuel, V.T., Petersen, K.F., et al. The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes. Nature 510 (2014), 84–91.
23. 23 Cruz, M.L., Bergman, R.N., Goran, M.I., Unique effect of visceral fat on insulin sensitivity in obese Hispanic children with a family history of type 2 diabetes. Diabetes Care 25 (2002), 1631–1636.
24. 24 Taksali, S., Caprio, S., Dziura, J., et al. High visceral and low abdominal subcutaneous fat stores in the obese adolescent: a determinant of an adverse metabolic syndrome. Diabetes 57 (2008), 367–371.
25. 25 Cali, A.M.G., De Oliveira, A., Kim, H., et al. Glucose dysregulation and hepatic steatosis in obese adolescents: is there a link?. Hepatology 49 (2009), 1896–1903.
26. 26 D'Adamo, E., Cali, A.M., Weiss, R., et al. Central role of fatty liver in the pathogenesis of insulin resistance in obese adolescents. Diabetes Care 33 (2010), 1817–1822.
27. 27 Fabbrini, E., Magkos, F., Mohammed, B.S., et al. Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity. Proc Natl Acad Sci U S A 106 (2009), 15430–15435.
28. 28 Fabbrini, E., Sullivan, S., Klein, S., Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications. Hepatology 51 (2010), 679–689.
29. 29 Burgert, T.S., Taksali, S.E., Dziura, J., et al. Alanine aminotransferase levels and fatty liver in childhood obesity: associations with insulin resistance, adiponectin, and visceral fat. J Clin Endocrinol Metab 91 (2006), 4287–4294.
30. 30 Nadeau, K.J., Klingensmith, G., Zeitler, P., Type 2 diabetes in children is frequently associated with elevated alanine aminotransferase. J Pediatr Gastroenterol Nutr 41 (2005), 94–98.
31. 31 Newton, K.P., Hou, J., Crimmins, N., et al. Prevalence of prediabetes and type 2 diabetes in children with nonalcoholic fatty liver disease. JAMA Pediatr, 170, 2016, e161971.
32. 32 Eckel, R.H., Obesity and heart disease: a statement for healthcare professionals from the Nutrition Committee, American Heart Association. Circulation 96 (1997), 3248–3250.
33. 33 Kahn, S.E., Hull, R.L., Utzschneider, K.M., Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 444 (2006), 840–846.
34. 34 Calle, E.E., Kaaks, R., Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 4 (2004), 579–591.
35. 35 Peeters, A., Barendregt, J.J., Willekens, F., et al. Obesity in adulthood and its consequences for life expectancy: a life-table analysis. Ann Intern Med 138 (2003), 24–32.
36. 36 Danforth, E. Jr., Failure of adipocyte differentiation causes type II diabetes mellitus?. Nat Genet, 26, 2000, 13.
37. 37 Ravussin, E., Smith, S.R., Increased fat intake, impaired fat oxidation, and failure of fat cell proliferation result in ectopic fat storage, insulin resistance, and type 2 diabetes mellitus. Ann N Y Acad Sci 967 (2002), 363–378.
38. 38 Gray, S.L., Vidal-Puig, A.J., Adipose tissue expandability in the maintenance of metabolic homeostasis. Nutr Rev 65 (2007), S7–S12.
39. 39 Virtue, S., Vidal-Puig, A., Adipose tissue expandability, lipotoxicity and the metabolic syndrome–an allostatic perspective. Biochim Biophys Acta 1801 (2010), 338–349.
40. 40 Kursawe, R., Eszlinger, M., Narayan, D., et al. Cellularity and adipogenic profile of the abdominal subcutaneous adipose tissue from obese adolescents: association with insulin resistance and hepatic steatosis. Diabetes 59 (2010), 2288–2296.
41. 41 Kursawe, R., Caprio, S., Giannini, C., et al. Decreased transcription of ChREBP-alpha/beta isoforms in abdominal subcutaneous adipose tissue of obese adolescents with prediabetes or early type 2 diabetes: associations with insulin resistance and hyperglycemia. Diabetes 62 (2013), 837–844.
42. 42 Gillum, M.P., Kotas, M.E., Erion, D.M., et al. SirT1 regulates adipose tissue inflammation. Diabetes 60 (2011), 3235–3245.
43. 43 Hotamisligil, G.S., Inflammation and metabolic disorders. Nature 444 (2006), 860–867.
44. 44 Lumeng, C.N., Saltiel, A.R., Inflammatory links between obesity and metabolic disease. J Clin Invest 121 (2011), 2111–2117.
45. 45 Odegaard, J.I., Chawla, A., Mechanisms of macrophage activation in obesity-induced insulin resistance. Nat Clin Pract Endocrinol Metab 4 (2008), 619–626.
46. 46 Olefsky, J.M., Glass, C.K., Macrophages, inflammation, and insulin resistance. Annu Rev Physiol 72 (2010), 219–246.
47. 47 Shoelson, S.E., Lee, J., Goldfine, A.B., Inflammation and insulin resistance. J Clin Invest 116 (2006), 1793–1801.
48. 48 Sbarbati, A., Osculati, F., Silvagni, D., et al. Obesity and inflammation: evidence for an elementary lesion. Pediatrics 117 (2006), 220–223.
49. 49 Tam, C.S., Tordjman, J., Divoux, A., et al. Adipose tissue remodeling in children: the link between collagen deposition and age-related adipocyte growth. J Clin Endocrinol Metab 97 (2012), 1320–1327.
50. 50 Dietz, W.H., Critical periods in childhood for the development of obesity. Am J Clin Nutr 59 (1994), 955–959.
51. 51 Spalding, K.L., Arner, E., Westermark, P.O., et al. Dynamics of fat cell turnover in humans. Nature 453 (2008), 783–787.
52. 52 Bjorntorp, P., Effects of age, sex, and clinical conditions on adipose tissue cellularity in man. Metabolism 23 (1974), 1091–1102.
53. 53 Hirsch, J., Batchelor, B., Adipose tissue cellularity in human obesity. Clin Endocrinol Metab 5 (1976), 299–311.
54. 54 Stienstra, R., van Diepen, J.A., Tack, C.J., et al. Inflammasome is a central player in the induction of obesity and insulin resistance. Proc Natl Acad Sci U S A 108 (2011), 15324–15329.
55. 55 Stienstra, R., Joosten, L.A., Koenen, T., et al. The inflammasome-mediated caspase-1 activation controls adipocyte differentiation and insulin sensitivity. Cell Metab 12 (2010), 593–605.
56. 56 Youm, Y.H., Adijiang, A., Vandanmagsar, B., et al. Elimination of the NLRP3-ASC inflammasome protects against chronic obesity-induced pancreatic damage. Endocrinology 152 (2011), 4039–4045.
57. 57 Vandanmagsar, B., Youm, Y.H., Ravussin, A., et al. The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance. Nat Med 17 (2011), 179–188.
58. 58 Wen, H., Gris, D., Lei, Y., et al. Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling. Nat Immunol 12 (2011), 408–415.
59. 59 Schroder, K., Zhou, R., Tschopp, J., The NLRP3 inflammasome: a sensor for metabolic danger?. Science 327 (2010), 296–300.
60. 60 Kursawe, R., Dixit, V.D., Scherer, P.E., et al. A role of the inflammasome in the low storage capacity of the abdominal subcutaneous adipose tissue in obese adolescents. Diabetes 65 (2016), 610–618.
61. 61 Huang, T.T., Johnson, M.S., Figueroa-Colon, R., et al. Growth of visceral fat, subcutaneous abdominal fat, and total body fat in children. Obes Res 9 (2001), 283–289.
62. 62 Bennett, B., Larson-Meyer, D.E., Ravussin, E., et al. Impaired insulin sensitivity and elevated ectopic fat in healthy obese vs. nonobese prepubertal children. Obesity (Silver Spring) 20 (2012), 371–375.
63. 63 Rebrin, K., Steil, G.M., Mittelman, S.D., et al. Causal linkage between insulin suppression of lipolysis and suppression of liver glucose output in dogs. J Clin Invest 98 (1996), 741–749.
64. 64 Perry, R.J., Camporez, J.P., Kursawe, R., et al. Hepatic acetyl CoA links adipose tissue inflammation to hepatic insulin resistance and type 2 diabetes. Cell 160 (2015), 745–758.